Minovia Therapeutics is a clinical-stage international biotechnology company, established in hopes to bring life changing therapies to patients with Mitochondrial diseases, as fast as responsible.
Following compassionate use cases performed in Sheba Medical hospital in Israel, using our proprietary Mitochondrial Augmentation Therapy, Minovia is now conducting the first of its kind clinical trial for Pearson syndrome, an ultra-rare pediatric disease.
Following compassionate use cases performed in Sheba Medical hospital in Israel, using our proprietary Mitochondrial Augmentation Therapy, Minovia is now conducting the first of its kind clinical trial for Pearson syndrome, an ultra-rare pediatric disease.
Location: Israel, Haifa District, Haifa
Employees: 11-50
Founded date: 2012
Investors 1
| Date | Name | Website |
| 20.02.2025 | 4T Venture... | 4t.venture... |
Mentions in press and media 2
| Date | Title | Description |
| 21.12.2022 | In a first, children with rare genetic diseases get mitochondrial transplants from their mothers | At a far distant point in Earth’s ancient past, two separate, single-celled life forms — an archaeon and a bacteria — became one in an act either of symbiosis or enslavement, depending on which microbiologist you ask. And over the next 2 bi... |
| 23.02.2021 | Four exciting companies receive expert mentoring | Four promising healthcare start-ups have proven the viability of their innovations and business plans in a competitive EIT Health Gold Track workshop in February. These start-ups have been selected to progress to the next stage of the prog... |